ZYDUSLIFE

CMP: Around ₹1,100–1,112 52-Week High: ₹1,128.50 52-Week Low: ₹835.50 Market Cap: ₹1.11 lakh crore P/E: 20–22x (depending on the data source) ROE: 21%+ Fundamental Positives ✅ Strong growth in US generics and specialty products. Healthy balance sheet and consistent profit growth over the last 5 years. FDA approvals and expansion in specialty drugs are supporting long-term growth. Company announced a large share buyback and later increased the buyback price to ₹1,260, showing management confidence.